APOB and coronary artery disorder: Mendelian randomisation analysis was used to estimate for each SNP cluster CHD odds ratios per 10 mg/dL apoB and per 0.33 mmol/L non-HDL-cholesterol, and to evaluate association of TRL/remnants with biomarkers of systemic inflammation.